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Abstract
Brain and vascular cells form a functionally integrated signalling network that is known as the neurovascular unit (NVU). The
signalling (autocrine, paracrine and juxtacrine) between different elements of this unit, especially in humans, is difficult to
disentangle in vivo. Developing representative in vitro models is therefore essential to better understand the cellular
interactions that govern the neurovascular environment. We here describe a novel approach to assay these cellular
interactions by combining a human adult cerebral microvascular endothelial cell line (hCMEC/D3) with a fetal ganglionic
eminence-derived neural stem cell (hNSC) line. These cell lines provide abundant homogeneous populations of cells to
produce a consistently reproducible in vitro model of endothelial morphogenesis and the ensuing NVU. Vasculature-like
structures (VLS) interspersed with patches of differentiating neural cells only occurred when hNSCs were seeded onto a
differentiated endothelium. These VLS emerged within 3 days of coculture and by day 6 were stabilizing. After 7 days of
coculture, neuronal differentiation of hNSCs was increased 3-fold, but had no significant effect on astrocyte or
oligodendrocyte differentiation. ZO1, a marker of adherens and tight junctions, was highly expressed in both
undifferentiated and differentiated endothelial cells, but the adherens junction markers CD31 and VE-cadherin were
significantly reduced in coculture by approximately 20%. A basement membrane, consisting of laminin, vitronectin, and
collagen I and IV, separated the VLS from neural patches. This simple assay can assist in elucidating the cellular and
molecular signaling involved in the formation of VLS, as well as the enhancement of neuronal differentiation through
endothelial signaling.
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Introduction
The neurovascular unit (NVU) is the quintessential organiza-
tional principle of functional brain tissue [1]. Signaling between
the vascular and neural cells is a key physiological process
regulating the interaction between peripheral circulation and
brain activity. At the interface of the vascular and neural
compartments is the blood-brain barrier (BBB) that limits the
access of molecules and peripheral cells to the brain. In the healthy
brain, neuronal and glial activity will influence vascular function
by neurovascular coupling to regulate their energetic demands by
maintaining tissue oxygenation and nutrient influx [2]. In the case
that this energetic demand is not met, a rapid physiological
response to hypoxia (i.e. lack of sufficient oxygenation) induces an
angiogenic cascade that aims to restore tissue oxygenation [3].
Angiogenesis, a growth of new vessels from existing vessels,
increases the vascular density and warrants adequate tissue
oxygenation. In brain tumors, the continued growth of the
‘‘neural’’ compartment is perpetuating a state of mild hypoxia,
hence producing an ongoing angiogenesis [4]. In contrast, in
stroke, where blood flow to brain tissue is blocked for protracted
periods of time, cells will die. Nevertheless, peri-infarct regions
undergo a mild hypoxia engendering a vascular response
encompassing vasculogenesis, angiogenesis, arteriogenesis and
collateral growth [5]. This leads to heteregeneous peri-infarct
areas of neo- and hypervascularization [6].
In the peri-infarct regions of a stroke, a local increase in
neovascularization is also observed after implantation of neural
stem cells (NSCs) [7,8] and has been suggested by some to mediate
behavioral improvements [9,10]. It is conceivable that these cells
have a propensity to directly act on the host vasculature, but the
increase of energetic demand in the area of implantation due to an
increase of cellular density can also induce mild hypoxia that
promotes neovascularization. It is important to note that NSCs
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injected into a stroke cavity with bioscaffolding by themselves do
not lead to re-vascularization [11,12], a common problem
observed in tissue engineering [13,14]. Strategies aimed at
modulating the vascular response following a stroke [15] or
NSC transplantation [9,10], vascularization of engineered tissues
[16], as well as inhibition of angiogenesis in brain tumors [17] are
grounded on a thorough understanding of the dynamic paracrine,
autocrine and juxtacrine interactions in the NVU [18,19].
However, parceling out these interactions in vivo, especially in
humans, is extremely challenging. Therefore the development of
in vitro models that afford a high level of experimental control and
reproducibility is required to complement in vivo studies [20].
Although a variety of in vitro models have been developed to
investigate angiogenesis [21] and the BBB [22], as well as the
NVU using rodent cells [23], assays composed of only human cells
investigating the formation of vasculature-like structures (VLS) of
brain microvascular endothelial cells by interacting with brain
cells, i.e. establishing a neurovascular environment, are generally
lacking. Although co-culturing of hNSCs with non-CNS endothe-
lial cells, such as Human Umbilical Vein Endothelial Cells
(HUVECs), have been reported to identify paracrine factors that
promote hNSCs proliferation [24], as well as angiogenesis-
promoting factors [25], these do not model the interaction
between hNSC and brain endothelium. Transwell experiments
only investigate paracrine and autocrine factors, whereas extra-
cellular matrix models, such as the Matrigel assay, are predom-
inantly biased towards juxtacrine factors [26], hence these are
more suitable to investigate a specific type of factors rather than
their synergistic and iterative effects. However, given the
appropriate conditions, endothelial cells will organize in vitro into
a net of VLS, akin to a vascular bed in tissue. An in vitro model of
the neurovascular environment therefore needs to involve direct
cell-to-cell contact between endothelial and ‘‘brain’’ cells, while
forming a network of VLS, hence affording the investigation of the
dynamic interactions of the formation of a neurovascular
environment, as well as the processes involved in angiogenesis in
the brain.
We here describe an all-human in vitro model that affords
controlled and detailed investigations of interactions between
previously validated brain microvascular endothelial and neural
stem cell lines, while forming a network of VLS. The resulting
cytoarchitecture is reminiscent of the neurovascular environment
with endothelial cells organized into a vasculature-like structure
surrounded by astrocytes, neurons and oligodendrocytes.
Materials and Methods
Human neural stem cell (hNSC) line
The derivation of the c-mycERTAM transduced hNSC line
STROC05 (ECACC accession number 04110301, provided by
ReNeuron Ltd., Surrey, UK) has been previously described [27].
In brief, hNSCs were isolated from the whole ganglionic eminence
of a human fetus at 12 weeks of gestation. The cells were
transduced with the retroviral vector pLNCX-2 (Clontech)
encoding the c-mycERTAM gene [28]. Expansion and mainte-
nance of STROC05 cells were performed in tissue culture flasks
(BD Biosciences) coated with mouse laminin (Sigma-Aldrich,
L2020) at a concentration of 10 mg/ml at 37uC in 5% CO2.
STROC05 cells were cultured in serum-free medium consisting of
DMEM:F12 medium (Sigma) containing 5 mg/ml insulin (Sigma),
100 mg/ml transferrin (Sigma), 40 ng/ml sodium selenite (Sigma),
60 ng/ml progesterone (Sigma), 16.2 mg/ml putrescine (Sigma),
0.03% human albumin solution (GemBio), 400 ng/ml L-thyroxine
(Sigma), 337 ng/ml tri-iodo-thyronine (Sigma), 10 units/ml
heparin sodium (Sigma), 40 ng/ml corticosterone (Sigma), and
2 mM L-glutamine (Sigma) (Table S1). Recombinant human basic
fibroblast growth factor (bFGF; 10 ng/ml; PeproTech), epidermal
growth factor (EGF; 20 ng/ml; PeproTech), and 4-hydroxyta-
moxifen (100 nM; Sigma) were added as mitogens. The cells were
passaged and used for experiments when they reached 70–80%
confluency.
Human cerebral microvascular endothelial cell (hCMEC/
D3) line
The immortalized human cerebral microvascular endothelial
cell line (hCMEC/D3) was isolated from microvessel fragments of
the temporal lobe of an adult with epilepsy by coexpressing human
telomerase reverse transcriptase and simian vacuolating virus 40
(hTERT/SV40) large T antigen via a lentiviral vector transduc-
tion system [29]. This cell line has been widely used as an in vitro
model of human brain endothelium [30]. The cell line was
expanded and maintained in tissue culture flasks (BD Biosciences)
coated with rat tail collagen type I (BD Biosciences, 354236) at a
concentration of 150 mg/ml at 37uC in 5% CO2, using endothelial
basal medium-2 (EBM-2; Lonza), supplemented with 5% fetal
bovine serum ‘‘Gold’’ (PAA, The Cell Culture Company), 5 mg/
ml ascorbic acid (Sigma), 1% chemically defined lipid concentrate
(Invitrogen), 10 mM HEPES buffer (Sigma), and 1% penicillin/
streptomycin (Invitrogen) (Table S1). hCMECs were used between
passages 28 and 32. Cells were passaged at 95% confluency.
Endothelial morphogenesis – Matrigel assay
The Matrigel (BD Biosciences, 356237) endothelial branching
morphogenesis assay establishes the potential of ECs to form
tubular networks (also known as capillary-like structures, CLS)
[31]. For this, 300 ml Matrigel (10.4 mg/ml, not diluted) was
added to the wells of 24-well plates and allowed to gel at 37uC for
30 minutes. Then 40,000 hCMECs were added to each well and
allowed to invade the material for 48 hours. As a positive control
for this assay, an immortalized microvascular EC line (HMEC-1)
derived from human foreskins was used [32]. HMEC-1 cells were
expanded in MCDB131 (Sigma), supplemented with 10% fetal
calf serum (Sigma), and 1% penicillin/streptomycin (Invitrogen).
The Matrigel endothelial morphogenesis assay confirmed the
branching phenotype in both hCMEC and HMEC-1 lines
(Fig. 1A). hCMECs therefore have the potential for endothelial
morphogenesis, but when cultured on a collagen-coated surface,
hCMECs are organized in an extensive and homogeneous
cobblestone-like monolayer displaying a brain microvascular
morphology with tightly packed elongated cells (Fig. 1B), as well
as characteristics of the BBB [29].
In vitro modeling of the neurovascular unit – Culture
media
D3 hCMECs and STROC05 hNSCs utilize medium of
different composition. To coculture these, it is therefore essential
to determine how these different media or their combination affect
cell morphology and culture consistency (e.g. attachment charac-
teristics, density). Culture media specific to D3 (EC medium) or
STROC05 cells (NSC medium) were used in monoculture to
expand cells until they reached confluency on coverslips (VWR,
89015-724) coated either with collagen I (hCMECs) or laminin
(hNSCs) in 24-well plates. Media were then replaced every other
day with either EC or NSC medium without addition of mitogens
and tamoxifen (i.e. differentiation media), or a 50:50 mix of
EC:NSC media (Table S1). Cell morphology was evaluated 7 days
later. EC medium resulted in both D3 hCMECs and STROC05
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Figure 1. Establishing branching phenotype of endothelial cells and media for coculture with neural stem cells. (A) Matrigel branching
morphogenesis assay confirmed the potential for endothelial morphogenesis in D3 human cerebral microvasculature endothelial cells (hCMECs) and
HMEC-1 dermal EC lines. (B) D3 hCMECs in EC medium formed a cobblestone-like monolayer on collagen-coated surfaces. D3 hCMECs in NSC medium
started to detach from culture surfaces, and STROC05 human neural stem cells (hNSCs) in EC medium lost bipolar elongated morphology. In
comparison, morphology of D3 hCMECs and STROC05 hNSCs was maintained in a 50:50 mix of EC:NSC medium. Diamidino-2-phenylindole (DAPI,
blue) serves as a nuclear counterstain. Scale bars represent 200 mm.
doi:10.1371/journal.pone.0106346.g001
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hNSCs adapting a dense cobblestone morphology without
extension of filopodia (Fig. 1B). In contrast, NSC medium lead
to detachment of hCMECs and reduced density and cell
differentiation. The 50:50 media mix provided the most consistent
cell morphology of both cell lines, while preserving robust
attachment and cellular density. hNSCs preserved their ability to
extend filopodia in the mixed medium. The EC:NSC serum-free
coculture media mix therefore retained both hCMEC and hNSC
features and was consequently used for all coculture experiments.
In vitro modeling of the neurovascular unit –
Experimental set-up
A major advantage of in vitro models over in vivo models is the
greater experimental control over the cellular and molecular
interactions being investigated. The use of two cell lines here
provides an opportunity to study various aspects of EC-NSC
interaction ranging from how particular molecules affect a single
cell type (monoculture), to the effects of secreted (paracrine &
autocrine) factors in a transwell assay, as well as the interaction
between differentiated and undifferentiated cells when these are
cocultured (paracrine, autocrine & juxtacrine factors combined).
Typically, 7 days of coculture are sufficient to investigate these
dynamic interactions (Figure 2A). The following conditions have
been investigated here (Fig. 2B):
Monoculture – modeling cell line specific features. To
investigate hCMECs or hNSCs interactions, hCMECs (40,000
cells) or hNSCs (25,000 cells) were grown in monoculture in a 24-
well plate using 50:50 EC:NSC coculture media (500 ml). Glass
coverslips (VWR, 89015-724) in the wells were coated either with
collagen I or laminin. This condition provides a key comparison to
establish how cellular signaling and behavior within single cell type
is influenced by the presence of specific molecules (secreted and/or
juxtacrine). It therefore provides an important control condition
compared to conditions where different cell types are cultured
together. Culture medium was replaced every other days and cells
were fixed after 7 days with 4% paraformaldehyde (PFA) or 95%
ethanol for 10 minutes, rinsed with phosphate buffered saline
(PBS), and stored in PBS at 4uC.
hCMEC–hNSC transwell assay – modeling the influence
of secreted factors only. The use of a transwell allows secreted
(autocrine & paracrine) factors to distribute in the culture media
and influence cell behavior without the contribution of juxtacrine
factors. Here, transwell inserts (Transwell with 0.4 mm pore
polyester membrane insert, Corning, 3470) were coated with
mouse laminin (Sigma-Aldrich, L2020) at a concentration of
10 mg/ml at 37uC in 5% CO2 for 2 h. Then STROC05 cells were
seeded into transwell inserts at a density of 5,000 cells per 0.33 cm2
area, for proliferation to 80% confluency. Meanwhile, D3 cells,
with a seeding density of 40,000 cells/well, were grown separately
on collagen-coated coverslips in 24-well plates for 7 days. The
transwell inserts containing STROC05 cells were then transferred
to the wells containing D3 cells, and these were cultured together
in serum-free coculture medium. The distance between the
transwell membrane and the bottom of the monolayer of D3 cells
was about 850 mm.
hCMEC:hNSC coculture of undifferentiated cells –
modeling the effects of proliferating cells on each
other. To model the interactions between hCMECs and
hNSCs, while both are proliferating and undifferentiated, 40,000
D3 cells and 25,000 STROC05 cells were combined and seeded
together onto glass coverslips (VWR, 89015-724) coated with a
mixture of 150 mg/ml collagen I and 10 mg/ml laminin in 24-well
plates, using serum-free coculture medium which did not contain
mitogens or tamoxifen to promote the continued proliferation of
hNSCs.
hNSC/hCMEC – modeling the effects of proliferating
endothelial cells on brain tissue. To model how proliferating
hCMECs affect brain cells, undifferentiated hCMECs (40,000
cells/well) were added to hNSC cultures (seeded at a density of
25,000 cells/well) that had been differentiated on laminin-coated
coverslips in 24-well plates for 7 days when there was an absence
of proliferating cells.
hCMEC/hNSC – modeling the effects of hNSCs implants
on host vasculature. To model the interactions hNSCs exert
on the host brain vasculature, undifferentiated hNSCs were added
to 7-day differentiated D3 cells. For this, D3 (40,000 cells/well)
were seeded on glass coverslips (VWR, 89015-724) coated with rat
tail collagen type I (BD Biosciences), using D3 EC medium, in 24-
well plates for 7 days. STROC05 (25,000 cells/well) were added
on day 8 in the presence of coculture medium. Only this condition
formed ‘‘spontaneous’’ VLS (Figure 2B), hence indicating that the
dynamic interactions between differentiated hCMECs and undif-
ferentiated hNSCs provided the sufficient signaling conditions for
novel neurovascular units to form. This condition was further
characterized as an assay to investigate how hNSCs induce the
formation of VLS by hCMECs.
Time course of vasculature-like structure formation
To establish a time course of VLS formation, hCMECs were
seeded (40,000 cells/well) and allowed to differentiate for 7 days
before hNSCs (25,000 cells/well) were added (hCEMC/hNSC
condition) and cocultured for 7 days. To investigate cytoarchitec-
tural changes resulting from cell movements, a series of time-lapse
images were photographed under a digital inverted microscope
(EVOS f1, AMG) by phase imaging. Coverslips were fixed each
day with 4% PFA, as described above.
Immunocytochemistry and image acquisition
For immunocytochemistry, cells were blocked with 10% normal
goat serum in PBS containing 0.1% Triton X-100 (Sigma) for
30 min prior to incubation with primary antibodies for 18 h at
4uC. The mouse anti-glial fibrillary acid protein (GFAP) (1:3000;
Sigma, G3893) specifically detected the astrocytic differentiation of
hNSC in vitro (,10% of undifferentiated cells were positive),
whereas the polyclonal chicken anti-glial fibrillary acid protein
(GFAP) (1:3000; Abcam, ab4674) was unspecific, detecting almost
100% of undifferentiated and .80% of differentiated hNSCs. The
polyclonal antibody was therefore used here to distinguish vascular
from neural compartments, whereas the monoclonal GFAP was
used to determine differentiation. Either the rabbit (1:200; Abcam,
ab28364) or mouse (1:200; Abcam, ab119339) anti-CD31/platelet
endothelial cell adhesion molecule 1 primary antibodies were used
to visualize endothelial cells representing the ‘‘vascular compo-
nent’’. Additionally, mouse anti-microtubule associate protein-2
(MAP2) (1:500; Abcam ab11267), mouse anti-galactocerebroside
(GalC) (1:200; Millipore MAB342), mouse anti-vascular endothe-
lial-cadherin (VE-cad) (1:200; Abcam ab7047), rabbit anti-zonula
occludens 1 (ZO1) (1:500; Zymed 40-2200), rabbit anti-occludin
(1:200; Abcam ab64482), rabbit anti-claudin-5 (1:200; Abcam
ab53765), mouse anti-intercellular adhesion molecule 2 (ICAM-2)
(1:200; Santa Cruz sc-9987), mouse anti-podocalyxin-like 1 (1:200;
Santa Cruz sc-23904), chicken anti-laminin (1:500; Abcam
ab14055), and goat anti-collagen IV (1:200; Millipore ab769)
primary antibodies were used for investigating differentiation
status of monoculture and coculture. After removal of primary
antibodies and washing with PBS (3x), cells were incubated with
appropriate secondary antibodies (goat anti-mouse Alexa 488-
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labeled, 1:1000; goat anti-rabbit Alexa 555-labeled, 1:1000,
Invitrogen) for 1 h at room temperature (22uC). Stained coverslips
were rinsed in PBS and mounted with Vectashield for fluorescence
with DAPI (Vector Laboratories). Fluorescence images were
captured using a fluorescence microscope (AxioImager M2, Zeiss),
a confocal laser-scanning microscope (Fluoview 1000, Olympus),
and a digital inverted microscope (EVOS f1, AMG).
Expression of endothelial markers, especially junctional pro-
teins, such as CD31, VE-cadherin, ZO1, ICAM-2, occludin,
claudin-5, exhibit a heterogeneous appearance that can reflect
typical in vivo localization of these markers at cellular junctions,
but can also reflect a cytoplasmic expression (Figure 3). The
cytoplasmic localization of these molecules is untypical of the
in vivo expression pattern of these markers on endothelial cells. It
is hence important to note that merely demonstrating the presence
of these proteins is not indicative of functional tight junctions.
Measuring the length of vasculature-like structure
To determine the efficiency of forming VLS (Figure 4A),
quantification of the formation of VLS was achieved using the
Stereo Investigator (MBF Bioscience) software. The extent of VLS
formation was evaluated by measuring the length of segments
between branching points (Figure 4B), as well as counting the
number of branching points. The total length of segments, as well
as the number of branching points were calculated to compare the
efficiency of VLS formation [33]. A few capillary-like segments
comprised a single layer of CD31+ cells between which a lumen-
like space formation were observed (Fig. 4C), but were not
representative of the overall formation of VLS.
Statistics
All experiments consisted of 3 biological replicates, each
consisting of 3 technical replicates. For each technical replicate,
5 images were taken from different areas on the coverslip prior to
calculating a mean value of cell counts for each coverslip. Using
SPSS 17 for Mac (IBM), a non-parametric Kruskall-Wallis was
used to compare different conditions followed by a Dunn’s post-
hoc comparison to determine which conditions were significantly
different (p,0.05). A Mann-Whitney U test was used to compare
the markers of differentiation between mono- and cocultures.
Graphs were drawn in Prism 5 (GraphPad) with data points
representing the median and bars reflecting the value range.
Results
Vasculature-like structures only form in direct contact
between differentiated endothelium and
undifferentiated neural stem cells
Monocultures of hCMECs on collagen I form a homogenous
cobblestone-like monolayer of cells, but do not organize into VLS
(Figure 2B). The organization of hCMECs into in vitro tubular
structures is therefore lacking the appropriate signaling. In the
NVU, endothelial cells interact with brain cells to form new
vessels. Therefore co-culturing these will allow us to determine
what signaling interactions are key to the organization of hCMECs
into new VLS. Secreted factors can be selectively investigated by
using a transwell approach, but these did not provide sufficient
signaling for hCMECs to form VLS (hCMEC-hNSC condition in
Figure 2B). As hCMECs form CLS in Matrigel, contact-mediated
factors, in addition to those secreted from hNSCs, might therefore
be required to form VLS. Combining undifferentiated hCMECs
and hNSCs or differentiated hNSCs with undifferentiated
hCMECs resulted in the formation of some VLS, although these
did not organize into a net-like connected structure. hCMECs only
efficiently formed VLS and net-like structures when first differen-
tiated and combined with undifferentiated hNSCs, indicating that
specific signaling conditions are required to induce a vasculogenic
process and that secreted factors by themselves are insufficient to
induce this process.
The co-culture of initially juxtaposed monolayers of differenti-
ated hCMECs and undifferentiated hNSCs resulted in a major
reorganization of cells. hCMEC organized into a vasculature-like
structure that formed a network interspersed by neural patches,
akin to the appearance of a neurovascular tissue (Figure 4A). To
assess the efficiency of the formation of VLS, the length of
individual segments of the network of VLS were measured
(Figure 4B). There was also occasionally evidence of the formation
of capillary-like structures (Figure 4C) that in contrast to VLS
were much thinner (1–2 endothelial cells in width), but these were
unrepresentative and only found in areas where endothelial cells
were mostly absent. The quantification of VLS segment length
supported the qualitative observation of VLS formation with no
VLS forming in the EC only or transwell condition, but some VLS
forming in contact-medicated co-culture conditions (undifferenti-
ated hCMEC and hNSC intermixed, differentiated hNSCs with
undifferentiated hCMEC seeded on top) (Figure 5, Kruskall
Wallis = 13.04, p,.01). However, these VLS formed very ineffi-
ciently compared to undifferentiated hNSC being seeded on top of
differentiated hCEMC. An almost 8 fold increase in efficiency
could be observed to the other contact co-culture conditions.
Cytoarchitectural characterization of vasculature-like
structures
Upon co-culturing of hNSCs with differentiated hCMEC,
hCMEC organize into a 3 dimensional structure of 8–10 hCMECs
in width (Figure 6A) with diameters ranging from 8–50 mm.
hNSCs cover the coverslip with hCMECs assembling and rising
above these into VLS (Figure 6B). Average length of VLS was
approximately 300 mm on day 7, but some longer structures up to
800 mm were also observed. hNSCs differentiated into astrocytes
(GFAP+ cells) overlying the 3 dimensional VLS (Figure 6C&D), a
specific anatomical feature of microvessels in the brain. Never-
theless, the VLS did not form a hollow lumen (Figure 6E).
VLS were clearly distinguishable based on their cellular density
and presence of CD31, an intercellular junction marker present in
endothelial cells, with astrocytes tightly bound around these
(Figure 7A). Nevertheless, CD31 was mostly localized within the
cytoplasm rather than at the intercellular junction typically
Figure 2. Protocols for EC/NSC coculture. (A) Schematic description of the protocols for monoculture and coculture of D3 human cerebral
microvascular endothelial cells (hCMECs) and STROC05 human neural stem cells (hNSCs). (B) 1. hCMECs (CD31+ cells) formed a dense monolayer on
the collagen-coated surface, but did not form vasculature-like structures (VLS). hNSCS (polyclonal GFAP+ cells) did not form any VLS. 2. In a transwell
coculture, only a dense monolayer of hCMECs without significant VLS could be found at the bottom of the lower chamber after 7 days of coculture. 3.
No significant VLS was found when hCMECs were seeded in combination with hNSCs. 4. No VLS emerged when hCMECs were seeded on 7-day
differentiated STROC05 cells. 5. A distinctive cytoarchitecture composed of CD31+ VLS and GFAP+ cells was observed when hNSCs were seeded on 7-
day differentiated hCMECs for a further 7 days of coculture. Diamidino-2-phenylindole (DAPI, blue) serves as a nuclear counterstain. Scale bars
represent 200 mm.
doi:10.1371/journal.pone.0106346.g002
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observed in endothelial cells in vivo. Only VLS expressed the
intercellular adhesion molecule 2 (ICAM-2) indicating ongoing
vessel formation, although parts of the VLS no longer expressed
ICAM-2 (Figure 7B). Conversely, parts of the VLS that appeared
more robust expressed Podocalyxin on the apical aspect of the
structure (Figure 7C), although these are devoid of a lumen.
Expression of Claudin-5 (Figure 7D) and Occludin (Figure 7E) is
evident, but is localized mostly inside the cells rather than the pints
of cell-cell contact. Nevertheless, the presence of these junctional
proteins by themselves is not an indication that functional tight
junctions are being formed in these VLS.
Figure 3. Immunohistochemistry of junctional markers on endothelial cells. Localization of ZO1 expression/detection was heterogeneous,
with it being only visible as part of the membrane (i.e. cellular junctions) on elongated and arranged endothelial cells (red arrows), but being mostly
cytoplasmic in clumped and non-elongated cells (yellow arrows). As the cytoplasmic expression is decreased (grey arrow), it gradually shifts towards
being exclusively present in the membrane.
doi:10.1371/journal.pone.0106346.g003
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A further cytoarchitectural feature of the neurovascular unit is
the formation of a basement membrane that separates the vascular
structure from the neural tissue. The non-apical aspect of the VLS
presented the characteristic basement membrane molecules
laminin, vitronectin, as well as collagen I & IV (Figure 8), further
indicating that the VLS are forming vascular elements of the
NVU. Collagen I was also expressed in approximately 50% of
non-endothelial cells, whereas the other 3 extracellular membrane
molecules were only found within the VLS.
Neurovascular morphogenesis is a gradual process
To visualize the process of endothelial morphogenesis leading to
the formation of VLS, a series of time-lapse images of hCMEC/
hNSC coculture were taken every 24 hrs for 7 days (Figure 9).
These images revealed that hCMECs responded to the presence of
hNSCs by increasing their spatial density through alignment, as
well as by adopting an elongated shape. This endothelial
morphogenesis, defining the emergence of VLS, was evident
within 72 hrs of coculture. In contrast, hNSCs infiltrated the
vacant space and further formed patches that increasingly defined
the VLS by providing mural support for hCMEC stacking. On
day 7 (168 hrs), the endothelial and neural space is distinctly
defined into two separate compartments. This time line indicates
that hCMECs adapt from a differentiated phenotype adhering to
the tissue culture substrate to preferentially adhering to other
endothelial cells and providing a substrate for adhesion of some
hNSCs.
A quantification of the VLS by immunohistochemistry over
7 days indicated a gradual process of VLS formation (Figure 10).
Initially, no defined VLS were readily identified, although an
interaction and movements of hCMECs and hNSCs were evident.
Figure 4. Quantification of endothelial morphogenesis. (A) A distinctive neurovascular cytoarchitecture emerged in which hCMECs (CD31+)
formed vasculature-like structures (VLS) resembling a vascular network in between patches of hNSCs (polyclonal GFAP+). (B) The efficiency of VLS
formation was quantified by measuring the length of segments between VLS branching points. (C) In a few samples, singular capillary-like structures
comprising single layers of CD31+ cells between which a lumen-like space formation was observed. Diamidino-2-phenylindole (DAPI, blue) serves as a
nuclear counterstain. Scale bars represent 50 mm.
doi:10.1371/journal.pone.0106346.g004
Figure 5. Comparison of efficiency to form vasculature-like
structures. Total length of VLS in hCMEC/hNSC coculture was more
efficient than any of the other culture conditions, including hCMEC
monoculture (hCMEC only), the transwell coculture (hCMEC-hNSC),
seeding of hCMECs and hNSCs simultaneously (hCMEC:hNSC), and
seeding hCMECs on differentiated hNSCs (hNSC/hCMEC). Data points
on the graph represent the median with bars reflecting the value range
(post-hoc pairwise comparisons: * p,.05; **p,.01).
doi:10.1371/journal.pone.0106346.g005
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Figure 6. 3-dimensional cytoarchitecture of vasculature-like structures. (A) A 3-dimensional cytoarchitecture composed of hCMECs (CD31+
cells in red) and hNSCs (polyclonal GFAP+ cells in green) was visualized using confocal microscopy. (B) At the base of the coculture, hNSCs were seen
in a monolayer on which hCMECs formed VLS that was characterized by a multicellular organization that extended beyond the monolayer to form a
unique structure. (C) Some hNSCs with an astrocytic phenotype were associated with these VLS by forming a layer of cells around the tubular walls in
some cases with an elongated morphology and endfeet on the VLS (yellow arrows). The astrocytes were ensheathing the VLS. (D) A higher
magnification 3D confocal image clearly demonstrates structural differences in astrocytes’ morphology upon interfacing with the VLS rather than
being inside the neural patch. (E) A 3-dimensional cut through this area further indicates that astrocytes provide structural support (white arrows) to
the VLS. The orange line indicates the monolayer formed by hNSCs onto which the VLS rests. Nevertheless, no hollow lumen is formed by the VLS. It
hence here remains unclear if a 3-dimensional support structure is required to create a lumen and if they are inflatable in a flow system. Diamidino-2-
phenylindole (DAPI, blue) serves as a nuclear counterstain. Scale bars represent 100 mm.
doi:10.1371/journal.pone.0106346.g006
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Hence the two juxtaposed monolayers gradually interchanged.
Clear structural differences between hCMECs and hNSCs
emerged that indicated a persisting endothelial morphogenesis in
which hNSCs accumulated in patches in between hCMECs and
gradually refined the endothelial morphogenesis. Eventually, a
well-defined network of VLS was evident with well-defined
patches of hNSCs. This gradual organization was also evident in
the linear increase in the length of VLS between 1 and 7 days, as
well as the number of branches in between these. However, the
slope of VLS length and the number of branches was significantly
different (F(1;38) = 121.068, p,.001) indicating a stepper increase
in the number of branches than the length of segments.
Figure 7. Cytoarchitectural characterization of vessel-like structures. (A) Astrocytes (monoclonal GFAP+ cells) form a layer of support
around endothelial cells that organize into tubular structures readily identified by phalloidin. (B) Tubular structures are tightly packed with
endothelial cells expressing intercellular adhesion molecule-2 (ICAM-2), although there is a degree of inconsistency in along the VLS indicating
different stages of development/maturity. (C) Endothelial cells organized into VLS are polarizing as indicated by the expression of the apical marker
podocalyxin that influences astrocytes positioning of endfeet. (D) Endothelial cells within the VLS also express markers indicative of tight junctions,
such as Claudin-5 and Occludin.
doi:10.1371/journal.pone.0106346.g007
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hCMECs increase neuronal differentiation of hNSCs
Apart of the formation of VLS, coculture of hCMECs with
hNSCs also affected their phenotype (Figure 11). Specifically,
neuronal differentiation (MAP2+ cells) of hNSCs significantly
increased by a factor of 3 in the presence of hCMECs (U=0, p,
0.05), whereas differentiation into oligodendrocytes (GalC+ cells)
or astrocytes (GFAP+ cells) was not significantly affected. CD31
(U= 0, p,0.05) and VE-cadherin (U= 0, p,0.05) on hCMECs
were downregulated in the presence of hNSCs indicating that the
integrity of intercellular junctions was not yet fully restored after
7 days of coculture, although ZO1 was expressed equally in co-
and monoculture. The phenotypic consequence of coculturing
therefore predominately affected neuronal differentiation for
hNSCs, whereas in hCMECs some intercellular junction proteins
were reduced reflecting the state of VLS maturation.
Discussion
The neurovascular unit (NVU) defines the organizational
principle of the brain by highlighting the importance of
interactions between the vascular and neural compartments [1].
We here present a novel, yet simple, in vitro model of human
brain neurovascular interactions that affords the investigation of
autocrine, paracrine and juxtracrine signaling between neural and
endothelial cells during the formation of VLS. Indeed, these
cocultures appear to model the neurovascular environment in
which VLS form a ‘‘vascular network’’ in between which neural
elements form patches of ‘‘neural tissue’’. This in vitro assay will
be essential to provide a detailed study of the cellular and
molecular interactions between these different cell types to validate
or generate novel hypotheses about neovascularization and the
NVU in the human brain [34].
In vitro models of the neurovascular environment and
the BBB
A key feature of neovascularization is the formation of novel
vessel structures from existing blood vessels. In the brain, this
process is evident in the case of growing tumors, but also after
brain damage, such as stroke, as well as injection of NSCs to
promote repair [35]. Although the basic mechanisms of neovas-
cularization in the brain are consistent with vasculogenesis,
angiogenesis, arteriogenesis or collateral growth in other organs,
important differences exist, specifically in terms of the stabilization
of vessels, where astrocytic endfeet directly interact with endothe-
lial cells with tight junctions being created to form the blood-brain
barrier [36]. Increasing evidence also suggests that processes
involving Wnt signaling and pericytes in the early phases of
neurovascular development are crucial for BBB formation [37,38].
Modeling of the BBB indeed has been the main focus of in vitro
models to determine its specific characteristics that afford transport
of molecules into the brain, a quintessential limitation for
delivering therapeutics to the brain by systemic administration
[30,39–41].
In vitro assays of the BBB, however, are mostly focused on the
barrier properties and hence these in vitro systems often rely on a
single endothelial layer or a dual layer system, where endothelial
cells form one layer and astrocytes form a second adjacent layer
[42–44]. In some cases, a tri-cellular environment is created by
adding pericytes to the astrocytes’ cell layer to more closely mimic
the cellular environment present at the BBB [22]. The formation
of a basement membrane is also considered a crucial characteristic
of this environment [44]. These approaches provide useful model
systems to study the barrier properties between the endothelial-
astrocytes complex, but they do not model the dynamic signaling
between vascular and neural elements during vascularization, nor
do they model the more complex NVU that also includes neural
cells.
The NVU is therefore a more complex structure in which a
multitude of cell-cell, cell-matrix and secreted factors from
different cell populations interact to form a functional network.
Indeed, this complexity is a challenge to examine these interac-
tions in vivo. In vitro models of cells derived from brain tissue are
hence indispensible to thoroughly analyze signaling interactions in
the NVU. To this end, it is imperative that not only astrocytes are
present in the ‘‘neural’’ compartment, but also neurons and
oligodendrocytes that form patches nested in between the vascular
tubules forming a network-like structure, as is observed in actual
brain tissue [23]. Indeed, after 7 days of coculture, we here
Figure 8. Deposition of a basement membrane and presence of tight junction molecules. Characteristic extracellular matrix molecules,
such as laminin, vitronectin, collagen I and IV, delineate the basement membrane which separates the vascular-like structures from the neural
environment.
doi:10.1371/journal.pone.0106346.g008
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observe these features that emerge due to the specific interaction
between hCMECs and hNSCs. Astrocytic and oligodendrocyte
differentiation was unaffected by endothelial morphogenesis, but
neural differentiation increased more than three-fold. Neverthe-
less, it remains unclear if this is a direct effect of endothelial cell
signaling on neural stem cells through the Notch-Delta pathway
[45] or if it is indirectly modulated through endothelial cells
affecting signaling from astrocytes and oligodendrocytes. Never-
theless, these questions can now be addressed using this in vitro
assay.
The formation of vasculature-like structures and
vasculogenesis
Understanding the role of vascularization in the adult brain is
essential to develop novel therapeutics; be it to block angiogenesis
in the case of brain tumors, to enhance neovascularization in the
case of stroke, or to promote vascularization of tissue engineered
structures [6]. Indeed, vascularization processes, such as vasculo-
genesis, angiogenesis, arteriogenesis, and collateral growth, share
many common molecular signaling pathways, although cellular
behavior in these processes is distinct due to their microenviron-
mental interactions [5,46]. To this end, it is essential that we
develop an understanding of the cellular and molecular processes
involved in forming novel vessel structures. The formation of
Figure 9. Time-lapse of vasculature-like structure formation. Time-lapse images revealed the gradual development of a neurovascular
cytoarchitecture in hCMEC/hNSC coculture. Arrowheads indicate the border of VLS that became prominent after coculture for 72 h. This solid
cytoarchitecture was fixed after an observation period of 168 h. The contrast at borders between hCMECs (CD31+ in red) and hNSCs (polyclonal
GFAP+ in green) areas was enhanced computationally. Diamidino-2-phenylindole (DAPI, blue) serves as a nuclear counterstain. Scale bar, 200 mm.
doi:10.1371/journal.pone.0106346.g009
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vasculature-like structures (VLS) in vitro is a process reflecting
vasculogenesis [5].
It is evident here that specific conditions are required in vitro
for this process to occur. The inability of secreted factors to
generate VLS is suggesting that additional components are
Figure 10. Time course of endothelial morphogenesis. Immunocytochemistry using antibodies against CD31 (red) and polyclonal GFAP
(green) revealed vascular morphogenesis in hCMEC/hNSC coculture with different culture durations of 1 to 7 days. The efficiency of endothelial
morphogenesis that produced vasculature-like structures, where hCMECs (CD31+) align to form rods, was assessed by measuring the length of these
rods (white lines), as well as the number of branching points between these for each image. Based on these quantifications, it was evident that total
length of all individual rods and the number of branching points increased over 7 days in a linear fashion. A linear regression allowed the calculation
of the slope of this progression and afforded a statistical comparison between both to indicate a significant difference in slope between VLS length
and branching points. Diamidino-2-phenylindole (DAPI, blue) serves as a nuclear counterstain. Scale bar, 100 mm. Data points on the graph represent
the median with bars reflecting the value range.
doi:10.1371/journal.pone.0106346.g010
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essential to induce endothelial morphogenesis. Merely adding
endothelial and neural cells together, however, to provide
juxtacrine, as well as paracrine and autocrine signals, is still
insufficient to promote novel vessel structures to form, although
endothelial – NSC cocultures have been demonstrated to provide
insight into their signaling interactions [19,45,47]. For endothelial
morphogenesis to occur, ECs and NSCs require specific signaling
which is dependent on their differentiation state leading to a
cascade of interactions involving autocrine, paracrine and
juxtacrine signals.
Specifically, a differentiated endothelium here was a necessary
condition for NSCs to induce VLS formation. The requirement of
close contact between both types of cells further indicates the
involvement of juxtacrine factors as key enablers. Interference with
juxtacrine factors, such as the vitronectin receptor avb3, prevents
angiogenesis [48]. Vitronectin is one of the earliest extracellular
matrix proteins deposited in the formation of the basement
membrane, providing a motif for NSCs to attach, but also
governing interactions between ECs, as they align for endothelial
morphogenesis. A variety of additional juxtacrine factors (e.g.
laminin) have been identified, but it remains unclear if all these
molecules define necessary conditions to induce VLS or if some of
these are merely modulating factors that influence the efficiency
and urgency of vessel formation [49].
A further complication is the potential synergistic effects of
secreted and juxtacrine factors. It remains currently unclear if
paracrine, autocrine and juxtacrine factors act as independent ‘‘go
– no go’’ signaling points for different processes (e.g. migration,
proliferation) or if the combination of these is required to control a
specific process. For instance for paracrine factors, it is already
Figure 11. Differentiation status in hCMEC/hNSC coculture. To determine the phenotypic effects of the coculture of hCMECs with hNSCs,
specific markers relevant to the differentiation of hNSCs into neurons (MAP2+), astrocytes (monoclonal GFAP+) and oligodendrocytes (GalC+), as well
as junction proteins in hCMECs (CD31, VE-cadherin, ZO1) were measured. There was a 3-fold increase in neuronal differentiation in coculture versus
monoculture, but no significant effect on astrocytic or oligodendrocyte differentiation. Apart of ZO1, the percentage of hCMECs expressing CD31 and
VE-cadherin was significantly reduced in coculture with hNSCs.
doi:10.1371/journal.pone.0106346.g011
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known that a combined signaling of transforming growth factor
(TGF)-b1 and bFGF is required to stabilize a vessel construct [50].
The specific timing of these factors at a particular site is pivotal to
facilitate subsequent steps involved in endothelial morphogenesis
[51]. Paracrine signaling might therefore provide the general
stimulus for a process (due to its more diffuse nature), but local
control over specifically which cells are responsive might be
controlled more tightly by juxtacrine factors. An in vitro system, as
described here, with human cell lines that can be modified to
provide ‘‘no go’’ points, as well as administration of blocking
agents at different decision points, will be a crucial tool to unravel
these processes further.
Limitations of the assay
It is important to point out that the assay described here is only
using human cell lines and hence provides a consistent source of
cells to reliably produce VLS embedded within neural compart-
ments. The availability of NSCs from different regions of the
human brain [27,28] further affords modeling of the NVU
representing different brain regions. Especially studies investigat-
ing hypoxia will benefit from these aspects, as it is known that, for
instance, hippocampal cells are more vulnerable than cortical cells
[52].
The formation of VLS in hCMEC/hNSC coculture suggests
that these two cell types provide the sufficient conditions to
produce an endothelial morphogenesis. Nevertheless, it is known
that additional cell types, such as pericytes and microglia, populate
the NVU in the brain [1]. Specifically, pericytes have been
associated with functions of the BBB [53] with measurements of
trans-endothelial electrical resistance being required to determine
barrier functions [26]. To serve as a ‘‘complete’’ model of the
BBB, it would be essential that the formed capillaries can be
perfused to determine if indeed a lumen can be formed and if
there is transfer of molecules from the vascular to the ‘‘neural’’
compartment [54]. Microglia have also been reported to be
involved in the formation of novel blood vessels and are a key
modulator of signaling that involves inflammatory cytokines [55].
Therefore to truthfully model the NVU to study, for instance,
signaling in hypoxia, it is essential to further expand the assay
described here to also include these types of cells.
A general limitation of in vitro NVU or vasculogenesis assays
are that they are conceived in 2 dimensions for ease of use, as well
as analysis. Although the VLS here expanded beyond the
monoculture during endothelial morphogenesis, this cannot truly
be considered a 3 dimensional environment, but rather a 2D+
culture environment [56]. As the NVU in the brain is a 3D
environment, a further advance will be to use, for instance,
biomaterials to create an artificial 3D environment in vitro [57].
However, care needs to be taken in developing these assays, as
biomaterials themselves can provide signaling, as in the case of
Matrigel. Eventually these further technical developments will
provide more realistic in vitro models of vessel formation and the
NVU in the human brain.
Conclusion
In vitro models of vessel formation and the NVU using only
human cells derived from brain tissues are essential to gain a more
thorough understanding of the molecular and cellular processes
that govern these in the living human brain. The assay described
here relies on human cell lines that afford an abundant availability
and high reproducibility. Most importantly, they form vasculature-
like structures defined by neural patches containing astrocytes,
oligodendrocytes and neurons and provide a model to study
neurovascular interactions in vitro. However, there are limitations
to this assay, specifically the lack of pericytes and microglia, as well
as a 3 dimensional tissue structure, which are key elements of the
neurovascular unit. Nevertheless, this assay of a neurovascular
environment will provide a useful tool to investigate the dynamic
interactions between human endothelial and neural stem cells
while forming and maintaining vasculature-like structures.
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